11/29
06:00 pm
irwd
What Catalysts Are Shaping the Changing Narrative for Ironwood Pharmaceuticals? [Yahoo! Finance]
Neutral
Report
What Catalysts Are Shaping the Changing Narrative for Ironwood Pharmaceuticals? [Yahoo! Finance]
11/26
04:06 pm
irwd
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025 [Seeking Alpha]
Medium
Report
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025 [Seeking Alpha]
11/11
09:44 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price target raised by analysts at Wells Fargo & Company from $1.00 to $3.00. They now have an "equal weight" rating on the stock.
High
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price target raised by analysts at Wells Fargo & Company from $1.00 to $3.00. They now have an "equal weight" rating on the stock.
11/10
07:33 am
irwd
Ironwood Pharmaceuticals Non-GAAP EPS of $0.24 beats by $0.12, revenue of $122.06M beats by $46.36M [Seeking Alpha]
High
Report
Ironwood Pharmaceuticals Non-GAAP EPS of $0.24 beats by $0.12, revenue of $122.06M beats by $46.36M [Seeking Alpha]
11/10
07:05 am
irwd
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
High
Report
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
11/6
06:56 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
9/9
05:56 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.